Oral Neutralizing Antibody Booster for Post-vaccinated People With COVID19 Vaccine

NACompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

June 1, 2021

Primary Completion Date

April 20, 2022

Study Completion Date

April 30, 2022

Conditions
COVID-19 Pandemic
Interventions
DIETARY_SUPPLEMENT

Bacillus subtilis spore extract

Bacillus subtilis, a harmless intestinal commensal, has earned in recent years, great reputation as a vaccine production host and delivery vector with advantages such as low cost, safe for human consumption and straightforward administration. The technology team has succeeded engineering Bacillus subtilis with spore coat proteins resembling the proteins of the nucleus and spikes of coronavirus. This product could have a vaccine like activity within the intestinal environment.

Trial Locations (1)

Unknown

Macao Greater Bay Area Association of Healthcare Providers, Macao

All Listed Sponsors
collaborator

DreamTec Cytokine Limited

UNKNOWN

lead

DreamTec Research Limited

INDUSTRY